Your browser is no longer supported. Please, upgrade your browser.
Settings
KERX Keryx Biopharmaceuticals Inc. daily Stock Chart
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.35 Insider Own2.10% Shs Outstand105.17M Perf Week11.65%
Market Cap675.19M Forward P/E- EPS next Y-0.71 Insider Trans0.53% Shs Float103.02M Perf Month-17.16%
Income-130.20M PEG- EPS next Q-0.26 Inst Own86.50% Short Float34.00% Perf Quarter-36.62%
Sales4.50M P/S150.04 EPS this Y-112.10% Inst Trans-2.97% Short Ratio22.07 Perf Half Y-48.27%
Book/sh1.41 P/B4.55 EPS next Y30.40% ROA-84.90% Target Price15.30 Perf Year-63.95%
Cash/sh1.25 P/C5.14 EPS next 5Y- ROE-106.80% 52W Range5.25 - 18.48 Perf YTD-54.63%
Dividend- P/FCF- EPS past 5Y-51.00% ROI-152.40% 52W High-65.26% Beta3.53
Dividend %- Quick Ratio5.00 Sales past 5Y-15.60% Gross Margin60.00% 52W Low22.29% ATR0.55
Employees155 Current Ratio6.30 Sales Q/Q- Oper. Margin- RSI (14)43.98 Volatility7.70% 8.45%
OptionableYes Debt/Eq0.01 EPS Q/Q-8.30% Profit Margin- Rel Volume0.67 Prev Close6.20
ShortableYes LT Debt/Eq0.01 EarningsAug 05 BMO Payout- Avg Volume1.59M Price6.42
Recom2.40 SMA200.44% SMA50-22.13% SMA200-44.40% Volume1,061,028 Change3.55%
Aug-13-15Initiated Morgan Stanley Underweight $3
Aug-11-15Initiated FBR Capital Mkt Perform $10
Aug-10-15Downgrade ROTH Capital Buy → Neutral $11 → $6
Aug-06-15Reiterated Maxim Group Buy $17 → $11
Jul-23-15Reiterated ROTH Capital Buy $23 → $11
May-06-15Reiterated Mizuho Buy $25 → $21
May-05-15Reiterated ROTH Capital Buy $27 → $23
May-05-15Reiterated Maxim Group Buy $32 → $17
Apr-20-15Reiterated Stifel Buy $19 → $17
Mar-20-15Reiterated Oppenheimer Outperform $22 → $18
Mar-02-15Reiterated Stifel Buy $22 → $19
Feb-27-15Reiterated ROTH Capital Buy $32 → $27
Feb-03-15Reiterated Mizuho Buy $30 → $25
Dec-02-14Reiterated FBR Capital Underperform
Nov-28-14Reiterated Maxim Group Buy $26 → $32
Nov-17-14Reiterated FBR Capital Underperform $14 → $12
Sep-22-14Resumed Oppenheimer Outperform $22
Sep-08-14Downgrade FBR Capital Mkt Perform → Underperform
Aug-14-14Initiated FBR Capital Mkt Perform $16
May-23-14Reiterated H.C. Wainwright Buy $19
Aug-28-15 05:15PM  3 Battleground Biotech Stocks I Would Avoid at All Costs at Motley Fool
09:57AM  5 Breakout Stocks to Trade for Big Gains at TheStreet
Aug-18-15 02:28PM  Mid-Day Market Update: Tuesday's Top Shorted Stocks
01:48PM  4 Reasons to Sell Keryx Pharmaceuticals at Motley Fool
Aug-15-15 01:04PM  KERYX BIOPHARMACEUTICALS INC Financials
Aug-13-15 06:19AM  Coverage initiated on Keryx Biopharma by Morgan Stanley -5.88%
Aug-10-15 08:14AM  No Longer A Buy: Roth Capital Downgrades Keryx Biopharma, Slashes Price Target To $6
Aug-08-15 08:10PM  10-Q for Keryx Biopharmaceuticals, Inc. at Company Spotlight
Aug-07-15 06:10AM  Biotech Stock Mailbag: Controversial Stocks Revisited at TheStreet -8.33%
Aug-06-15 06:00PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report -8.92%
02:42PM  Keryx Posts In-Line Loss in Q2, Auryxia in Focus - Analyst Blog
06:19AM  [$$] Keryx Shares Could Triple Despite Slower Sales at Barrons.com
Aug-05-15 03:05PM  Edited Transcript of KERX earnings conference call or presentation 5-Aug-15 12:00pm GMT
01:55PM  Keryx revenue falls short despite support of analysts, Baupost at bizjournals.com
09:05AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
08:29AM  Keryx's (KERX) Q2 Loss in-Line with Estimates - Tale of the Tape
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:18AM  Keryx Biopharma reports 2Q loss
07:07AM  Q2 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open
07:00AM  Keryx Biopharmaceuticals Announces Second Quarter 2015 Financial Results GlobeNewswire
Aug-04-15 07:04PM  Why Keryx Biopharmaceuticals Stock Plunged 18% in July at Motley Fool
03:41PM  5 Reasons to Buy Keryx Pharmaceuticals at Motley Fool
01:50PM  Will Keryx (KERX) Miss Estimates This Earnings Season? - Analyst Blog
Jul-28-15 04:05PM  Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2015 Financial Results on Wednesday, August 5, 2015 GlobeNewswire +5.61%
Jul-27-15 05:22PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
08:00AM  Keryx Biopharmaceuticals Appoints Scott A. Holmes as Chief Financial Officer GlobeNewswire
Jul-24-15 04:16PM  Why Shares of Keryx Biopharmaceuticals Fell Today at Motley Fool -15.33%
07:10AM  Keryx Receives CHMP Positive Opinion for Fexeric(R) (Ferric Citrate Coordination Complex) for the Treatment of Hyperphosphatemia in Adults With Chronic Kidney Disease GlobeNewswire
Jul-16-15 05:50PM  Faruqi & Faruqi, LLP is Investigating Keryx Biopharmaceuticals, Inc. (KERX) on Behalf of its Shareholders PR Newswire
Jul-07-15 07:43AM  Blame Keryx Executives, Not Short Sellers, for Dismal Drug Launch, Sinking Stock at TheStreet
Jul-06-15 07:10AM  How short sellers threaten innovations that could benefit patients at bizjournals.com
Jun-29-15 11:49PM  Edited Transcript of KERX presentation 24-Jun-15 6:30pm GMT
Jun-24-15 05:31PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:45AM  Boston drug company Keryx continues to shake off the haters at bizjournals.com
08:00AM  Keryx Announces Two National Insurance Providers Added Auryxia(TM) to Their Medicare Part D Formularies GlobeNewswire
Jun-17-15 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-16-15 09:00AM  Keryx Biopharmaceuticals to Present at the JMP Securities Life Sciences Conference 2015 GlobeNewswire
May-27-15 09:10AM  MKM Partners' 4 Health Care Stocks to Sell Before June at TheStreet
May-22-15 07:59PM  Billionaire Klarmans Top Small-Cap Picks: ViaSat Inc., Theravance Inc., PBF Energy at Insider Monkey
May-12-15 06:32PM  CORRECTING and REPLACING -- Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference GlobeNewswire
03:02PM  A battle brews between Baupost Group and short investors drug firm Keryx at bizjournals.com
08:51AM  Keryx Biopharmaceuticals (KERX) Jumps: Stock Up 14.8% - Tale of the Tape
May-07-15 04:05PM  Keryx CEO 'pleased' with drug launch as firm expands in Boston at bizjournals.com
May-06-15 08:12PM  10-Q for Keryx Biopharmaceuticals, Inc. at Company Spotlight
02:20PM  Is Isis just what the doctor ordered?
06:32AM  Keryx Hits Some Kinks at Barrons.com
May-05-15 06:03PM  Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference at noodls
04:30PM  Keryx Biopharmaceuticals to Present at Bank of America Merrill Lynch 2015 Health Care Conference GlobeNewswire
01:00PM  Keryx Biopharmaceuticals Posts In-line Loss, Revenue Beat - Analyst Blog
May-04-15 04:04PM  The 52-Week Low Club for Monday at 24/7 Wall St.
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:33AM  Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results at noodls
07:21AM  Keryx Biopharma reports 1Q loss
07:15AM  Keryx Biopharmaceuticals Announces First Quarter 2015 Financial Results GlobeNewswire
07:08AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q1 2015 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open
May-01-15 04:25PM  Will Keryx (KERX) Disappoint This Earnings Season? - Analyst Blog
Apr-30-15 05:37PM  Keryx Biopharmaceuticals Completes Transition of CEO Role to Greg Madison at noodls -5.16%
05:12PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
04:30PM  Keryx Biopharmaceuticals Completes Transition of CEO Role to Greg Madison GlobeNewswire
Apr-27-15 04:30PM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on First Quarter 2015 Financial Results GlobeNewswire
Apr-24-15 04:32PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-23-15 08:29AM  Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer at noodls
08:00AM  Keryx Biopharmaceuticals Appoints John F. Neylan, MD, as Chief Medical Officer GlobeNewswire
Apr-09-15 07:56AM  Keryx Biopharmaceuticals Live on Revenue Management Cloud Using Model N Express at noodls
Mar-26-15 07:33PM  Lightning Round: This was a 'one and done' at CNBC
Mar-18-15 04:15PM  Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors PR Newswire
Mar-17-15 09:23AM  Analyzing The Baupost Groups Holdings in 4Q14
Mar-15-15 09:09AM  Billionaire Seth Klarmans Biotech Stock Picks at Insider Monkey
Mar-10-15 05:37PM  Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors at noodls
05:01PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
04:55PM  Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors GlobeNewswire
Mar-04-15 08:05AM  Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology at noodls
08:05AM  Keryx Announces Fourth Quarter and Year-End 2014 Financial Results at noodls
07:45AM  Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology GlobeNewswire
Mar-02-15 12:10PM  Keryx Biopharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog
09:43AM  Keryx Spotlights Biotech Challenge at The Wall Street Journal
12:28AM  Overheard: Keryxs Value in Profits at The Wall Street Journal
Mar-01-15 03:39PM  Overheard: Keryx's Value in Profits at The Wall Street Journal
Feb-27-15 08:31AM  Keryx's (KERX) Q4 Loss Misses Expectation, Auryxia in Focus - Tale of the Tape Zacks
08:00AM  Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today CCBN
07:46AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations an EDGAR Online
07:15AM  Keryx Biopharma reports 4Q loss AP
07:07AM  Q4 2014 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open CCBN
07:00AM  Keryx Announces Fourth Quarter and Year-End 2014 Financial Results GlobeNewswire
Feb-26-15 10:50AM  What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Zacks
Feb-25-15 04:10PM  Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire
Feb-18-15 08:00AM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial Results GlobeNewswire
Feb-09-15 08:36AM  Well-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug Launch at TheStreet
Jan-27-15 04:35PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Jan-22-15 04:10PM  Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog Zacks
08:31AM  Keryx Biopharmaceuticals (KERX) in Focus: Stock Falls by 6.8% - Tale of the Tape Zacks
Jan-21-15 07:53PM  Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock GlobeNewswire -6.81%
01:38PM  4 More Biotech Secondaries Traders Are Watching Benzinga
08:55AM  Wednesday Morning Movers: Netflix Flying High Benzinga
Jan-20-15 04:05PM  Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock GlobeNewswire
Jan-12-15 08:40AM  Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors PR Newswire
07:19AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
01:04AM  Big deals, data kick off JPMorgan health conference at CNBC
Jan-11-15 10:00PM  Keryx Biopharmaceuticals Announces Transition of Leadership GlobeNewswire
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, as well as treats iron deficiency anemia. Auryxia is also used to control serum phosphorus levels in patients with chronic kidney disease on dialysis. The company also has sublicense agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Auryxia in Japan. It also has strategic alliance with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holmes Scott AChief Financial OfficerAug 21Buy5.725,00028,59054,742Aug 24 06:06 PM
Madison GregPresident and CEOAug 20Buy5.699,98456,759116,719Aug 24 06:10 PM
Neylan John F.Chief Medical OfficerAug 12Buy6.2010,00062,00055,000Aug 14 07:30 AM
Madison GregPresident and CEOAug 10Sale6.071,68310,216106,735Aug 12 07:00 PM
Holmes Scott AChief Financial OfficerJul 31Sale7.872,75821,70549,742Aug 03 07:30 PM
Adams BrianVP and General CounselJul 15Sale9.991,08610,84958,469Jul 17 08:00 PM
Oliviero James F IIIChief Financial OfficerMay 12Option Exercise2.6741,611111,095211,349May 12 07:57 PM
Adams BrianVP and General CounselApr 15Sale12.404,32053,56859,555Apr 17 07:00 PM
BENTSUR RONChief Executive OfficerApr 06Sale11.681,59218,595777,209Apr 08 08:00 PM
Oliviero James F IIIChief Financial OfficerApr 06Sale11.681,87821,935169,738Apr 08 08:01 PM
Madison GregPresident and COOFeb 09Sale10.956,75974,011103,663Feb 10 09:00 PM
BENTSUR RONChief Executive OfficerJan 05Sale13.795,57476,865778,801Jan 06 08:15 PM
Oliviero James F IIIChief Financial OfficerJan 05Sale13.795,60477,279171,616Jan 06 08:13 PM
BENTSUR RONChief Executive OfficerDec 30Sale14.11200,0002,822,000717,000Jan 02 09:30 PM
BENTSUR RONChief Executive OfficerDec 29Sale13.9887,9881,230,072917,000Dec 29 09:40 PM
BENTSUR RONChief Executive OfficerDec 26Sale13.9863,500887,7301,004,988Dec 29 09:40 PM
BENTSUR RONChief Executive OfficerDec 24Sale13.9883,0001,160,3401,068,488Dec 29 09:40 PM
BENTSUR RONChief Executive OfficerDec 23Sale13.98104,4891,460,7561,151,488Dec 29 09:40 PM
Oliviero James F IIIChief Financial OfficerDec 10Option Exercise11.2225,000280,500178,345Dec 12 08:01 PM
Oliviero James F IIIChief Financial OfficerDec 10Sale15.6925,000392,250153,345Dec 12 08:01 PM
BENTSUR RONChief Executive OfficerOct 06Sale15.8768,8001,091,856755,977Oct 07 08:00 PM
Oliviero James F IIIChief Financial OfficerOct 03Sale16.142,69443,481153,345Oct 07 08:00 PM
BENTSUR RONChief Executive OfficerOct 03Sale16.142,03832,893824,777Oct 07 08:00 PM
BENTSUR RONChief Executive OfficerSep 12Sale14.2450,000712,000826,815Sep 12 08:30 PM
Oliviero James F IIIChief Financial OfficerSep 08Sale15.88144,2372,290,484156,039Sep 10 08:00 PM